Bay Harbor Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bay Harbor Wealth Management's GILD Position: Q2 2026 in Review
Bay Harbor Wealth Management increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $3.56K and bringing the position to 174 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #185.
Bay Harbor Wealth Management first reported a position in GILD in Q4 2018 and has held it in 19 quarters since. The position peaked at $340K in Q1 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bay Harbor Wealth Management held 174 shares of Gilead Sciences worth $22K as of Q2 2026.
- Bay Harbor Wealth Management bought 27 Gilead Sciences shares in Q2 2026, an estimated $3.56K.
- Gilead Sciences made up 0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #185 holding.
- Bay Harbor Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 19 quarters since.
- Bay Harbor Wealth Management's Gilead Sciences position peaked at $340K in Q1 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.